Learn more about our policy experts.

Media Contacts

Angela Bradbery, Director of Communications
w. (202) 588-7741
c. (202) 503-6768
abradbery@citizen.org, Twitter

Don Owens, Deputy Director of Communications
w. (202) 588-7767

Karilyn Gower, Press Officer
w. (202) 588-7779

David Rosen, Press Officer, Regulatory Affairs
w. (202) 588-7742

Nicholas Florko, Communications Officer, Global Trade Watch
w. (202) 454-5108

Other Important Links

Press Release Database
Citizen Vox blog
Texas Vox blog
Consumer Law and Policy blog
Energy Vox blog
Eyes on Trade blog

Follow us on Twitter


Sept, 10, 2012

Letter Recommends Independent Investigation of NIH’s Failure to Promptly Disclose Superbug Outbreak at Research Hospital

Patients, Public Health Officials and Public Kept in the Dark

WASHINGTON, D.C. – The Department of Health and Human Services (HHS) should open an independent investigation into the National Institutes of Health’s (NIH) handling of information related to a deadly outbreak of multi-antibiotic-resistant Klebsiella bacterial infections at the research agency’s hospital facility known as the Clinical Center, in Bethesda, MD, Public Citizen said today in a letter addressed to HHS secretary Kathleen Sebelius.

The outbreak, which reportedly started in June 2011 and lasted through December 2011, was not announced to the public until August 22, 2012. In addition, the Maryland health department was not notified until December 2011, despite a state law requiring that such outbreaks be reported. The NIH’s failure to promptly inform all potentially affected patients, public health authorities and the public-at-large raises troubling concerns, the letter said.

Public Citizen urged HHS to seek answers to the following questions, among others:

• Why did the NIH fail to publicly disclose this deadly outbreak for one year after having evidence that the outbreak stemmed from a single source and after new cases of the superbug infection began to occur at a rate of approximately one per week?

• Once the NIH recognized the seriousness of the outbreak, why didn’t it mandate that all patients already admitted or being considered for admission to the Clinical Center be informed of the risk of exposure to the deadly Klebsiella superbug?

• Why did the NIH fail to promptly notify the Maryland health department and Montgomery County public health officials about the Klebsiella superbug outbreak?

The August 22 press release announcing the outbreak coincided with the release of a scientific paper in the on-line edition of the journal Science Translational Medicine that examined how NIH scientists used sophisticated bacterial genome sequencing techniques to track the spread of the infection from patient to patient.

“The timing of the belated NIH announcement was not determined by any public health considerations or the need to inform the public about this dangerous health threat,” said Dr. Michael Carome, deputy director of Public Citizen’s Health Research Group, “but rather by the desire to give itself a self-congratulatory pat on the back. This represents an egregious violation of a duty the NIH had to inform all potentially affected patients, public health authorities and the public at large about such threats.”

Public Citizen is also asking HHS to investigate the NIH’s preparedness for ensuring prompt disclosure and reporting of future outbreaks. The letter requests information on whether the NIH has now established formal policies for communicating information about such an event in the future.

“Unless a plan is in place for timely dissemination of information about this kind of potentially deadly outbreak, patients considering participation in clinical studies that may involve hospitalization at the NIH Clinical Center cannot weigh the risk of exposure to a superbug infection against the potential benefits of participation,” Carome said.

To read the letter, visit http://www.citizen.org/hrg2070.

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.


To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.